Gland Pharma Wins USFDA Approval for Generic Bridion Injection, Launches Product in US Written By sheeba farhat29 July 2026 10:32 PM ISTHyderabad: Gland Pharma Limited has received approval from the U.S. Food and Drug Administration (USFDA) for its Abbreviated New Drug Application...
Aurobindo Pharma Inks Voluntary Licensing Pact with MSD for HIV Prevention Medicine Written By sheeba farhat25 July 2026 6:38 PM ISTNew Delhi: Aurobindo Pharma Limited has entered into a non-exclusive voluntary licensing agreement with MSD (the trade name of Merck & Co., Inc.,...
Merck Signs Voluntary Licensing Deals with 7 Generic Drugmakers for Affordable HIV Pill in 129 Countries Written By sheeba farhat25 July 2026 6:22 PM ISTBengaluru: Merck said on Friday it signed seven voluntary licensing agreements with generic drug manufacturers to make and sell lower-cost versions of...
USFDA Approves Merck's First Oral PCSK9 Inhibitor Lipfendra for High LDL Cholesterol Written By sheeba farhat17 July 2026 4:10 PM ISTBengaluru: The U.S. FDA approved Merck's cholesterol-lowering pill, it said on Thursday, the first in a class of drugs dominated by injections,...
Merck Marks Beta Blocker Month: Revisiting a Landmark Discovery & Spotlight on Bisoprolol Written By Dr. Kamal Kant Kohli30 Jun 2026 11:57 AM ISTMerck is commemorating Beta Blocker Month in June by celebrating the discovery of beta-blockers, their lasting impact on cardiovascular care, and...
Pfizer's Sigvotatug Vedotin Misses Primary Survival Goal in Late-Stage Lung Cancer Trial Written By sheeba farhat24 Jun 2026 12:00 PM ISTBengaluru: Pfizer said its drug for a type of lung cancer missed the main goal of improving survival in patients compared to a generic drug in a...
Merck's CAPVAXIVE Gets USFDA Nod for Children, Adolescents at Increased Pneumococcal Disease Risk Written By Farhat Nasim19 Jun 2026 10:00 AM ISTNew Delhi: Global biopharmaceutical company Merck has announced that the U.S. Food and Drug Administration (USFDA) has approved an expanded indication...
Merck Explores Repurposing Molnupiravir for Rare Ebola Outbreak as Congo Cases Cross 1,100 Written By sheeba farhat2 Jun 2026 6:28 PM ISTChicago: Merck is in discussions with various global health authorities about making its COVID antiviral pill molnupiravir available as an Ebola...
Moderna, Merck Cancer Vaccine Combo Achieves 92% Survival Rate in Melanoma Trial Written By MD Bureau26 May 2026 5:58 PM ISTBengaluru: Moderna and Merck's combination therapy for skin cancer helped reduce risk of cancer spreading to another part of the body by 59% after...
Bristol Myers Squibb, China's Hengrui Sign USD 15.2 Billion Drug Collaboration Deal Written By MD Bureau14 May 2026 8:14 PM ISTNew Delhi: Jiangsu Hengrui Pharmaceuticals, China's biggest drugmaker by market value, on Tuesday said it struck global collaboration and licensing...
Merck Wins USFDA Approval for Dual-Drug HIV Therapy Idvynso Written By sheeba farhat22 April 2026 10:30 AM ISTNew Delhi: The U.S. Food and Drug Administration has approved Merck's once-daily, oral, combination regimen for HIV infections, the drugmaker said...
Merck's Enlicitide Outperforms Rivals in Cutting Bad Cholesterol in Late-Stage Trial Written By sheeba farhat1 April 2026 4:15 PM ISTBengaluru: Drugmaker Merck said on Monday its oral drug met the main goal of meaningfully reducing bad cholesterol in a late-stage head-to-head...
